Annual Report and Accounts for Year Ended 31 March 2015

Immunodiagnostic Systems Holdings plc (“IDS”) a leading producer of manual and automated specialist diagnostic testing kits and instrumentation for the clinical and research markets, confirms that its Annual Report and Accounts for the year ended 31 March 2015 and Notice of Annual General Meeting has today been published on the Company’s website. >View 2015 Annual […]


The First Fully-Automated TRAcP5b Assay An automated assay for the quantitative determination of Tartrate Resistant Acid Phosphatase 5b (TRAcP 5b) in human serum and heparin plasma.  The assay is intended for use as an aid in monitoring changes in bone metabolism in response to therapy. TRAcP is an enzyme that is released from active osteoclasts, […]

Join us at the 2014 AACC Annual Meeting & Clinical Lab Expo

Join us at the 2014 AACC Annual Meeting & Clinical Lab Expo (27th – 31st July 2014, IL, Chicago). IDS is expanding its automated immunoassay solutions for calcium, growth, bone, and hypertension disease areas. IDS-iSYS immunoassay system – optimises specialty testing in your laboratory without compromising quality Fully on-board IDS-iSYS 1,25 VitDXp* – simplifies laboratory workflow Fully […]

Family playing tug-of-war on a beach

FDA Clearance of Direct Renin Assay on IDS-ISYS

Immunodiagnostic Systems Holdings plc (“IDS” or ‘”the Company”) announces that it has received USA FDA (Food and Drug Administration) clearance for its Direct Renin assay for use on its IDS-iSYS system, enabling IDS to enter the US market with this product. The IDS-iSYS Direct Renin immunoassay is used to determine the amount of active renin […]